Emmanuel Favaloro2

发表

Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association

G. Lippi1, M. Montagnana1, Emmanuel Favaloro2, 2009 .

Genetics of type 2B von Willebrand Disease: “True 2B,” “tricky 2B,” or “Not 2B.” What Are the Modifiers of the Phenotype?

Emmanuel Favaloro2, Maha Othman1, Maha Othman1, 2008 .

Recombinant Platelet Factor 4: A Therapeutic, Anti-Neoplastic Chimera?

G. Lippi1, Emmanuel Favaloro2, 2010 .

Activated Partial Thromboplastin Time: New Tricks for an Old Dogma

G. Lippi, E. Favaloro, G. Lippi1, 2008, Seminars in thrombosis and hemostasis.

Recombinants in Thrombosis and Hemostasis: From Basic Research to Clinical Therapy

G. Lippi1, Emmanuel Favaloro2, 2010 .

Clinical Features, Diagnosis, and Management of the Antiphospholipid Syndrome

Emmanuel Favaloro2, Richard Wong1, 2008 .

A Consensus Approach to the Formulation of Guidelines for Laboratory Testing and Reporting of Antiphospholipid Antibody Assays

Emmanuel Favaloro2, Richard Wong1, 2008 .

Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part IV

G. Lippi1, Emmanuel Favaloro2, M. Franchini3, 2011 .

Milestones and Perspectives in Coagulation and Hemostasis

G. Lippi1, Emmanuel Favaloro2, M. Franchini3, 2009 .

Clinical Features, Diagnosis, and Management of the Antiphospholipid Syndrome

E. Favaloro, R. Wong, Emmanuel Favaloro2, 2008, Seminars in thrombosis and hemostasis.

Prevention of Venous Thromboembolism: Focus on Mechanical Prophylaxis

G. Lippi, G. Cervellin, E. Favaloro, 2011, Seminars in thrombosis and hemostasis.

A Consensus Approach to the Formulation of Guidelines for Laboratory Testing and Reporting of Antiphospholipid Antibody Assays

Emmanuel Favaloro2, Richard Wong1, 2008, Seminars in thrombosis and hemostasis.

Antiphospholipid Antibodies and the Antiphospholipid Syndrome I: Pathogenesis, Clinical Features, Diagnosis, and Management

Emmanuel Favaloro2, Richard Wong1, 2008, Seminars in thrombosis and hemostasis.